查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1373944

功能服務提供者（FSP）的全球市場預測（截至2027年）

Functional Service Providers (FSP) Market Research Report Forecast till 2027
出版日期: | 出版商: Market Research Future | 英文 141 Pages | 訂單完成後即時交付

價格

在研究期間，全球功能服務提供者 (FSP) 市場規模預計將以 7.49% 的複合年增長率健康成長。

該市場受到多種因素的推動，例如研發企業的擴張、臨床前試驗的增加以及藥物改進中 FSP 外包的增加。

不斷增加的研發活動，尤其是生物製藥和生技公司的研發活動，正在推動全球市場對功能服務提供者 (FSP) 的需求。研究表明，大型生物製藥公司對 FSP 的使用每年以超過 13% 的速度成長。

區域考慮

北美市場形成最大市場，2022年市佔率約41%。這是由於該地區擁有完善的醫療基礎設施、大量的臨床前研究以及 IQVIA（美國）、Parexel（美國）和 Labcorp Memination Improvement（美國）等關鍵參與者。

歐洲市場因技術創新不斷增加、醫療消費增加、慢性病盛行率上升而佔據第二大市場。據 EMA 稱，歐盟成員國在任何特定時間正在進行約 4,000 項臨床試驗。預計到 2022 年，德國將佔據最大的市場份額，而法國將成為歐洲成長最快的市場。

預計2023年至2027年亞太市場發展最快。

該報告研究和分析了全球功能服務提供者（FSP）市場，提供市場動態、區域和細分市場分析、公司概況等。

目錄

第一章執行摘要

第二章市場介紹

第三章研究方法

第四章市場動態

  • 概述
  • 促進者
    • 加大研發投入
    • 臨床試驗增加
    • 降低管理成本，提高服務品質
    • 藥物開發中 FSP 外包的增加
  • 抑製劑
    • 熟練工人短缺
  • 機會
    • 生物製藥和生物技術的數位轉型

第五章市場因素分析

  • 價值鏈分析
    • 客戶取得（購買前查詢）
    • 服務客製化
    • 客戶購買支援
    • 客戶履行/售後支持
  • 波特五力分析模型
  • COVID-19 對功能服務提供者 (FSP) 市場的影響
    • 概述
    • 對功能服務提供者 (FSP) 需求的影響

第六章全球功能服務供應商（FSP）市場：按類型

  • 概述
  • 臨床監測
  • 醫學寫作
  • 數據管理
  • 藥物警戒
  • 生物統計學/編程
  • 監管事務
  • 其他

第七章 全球功能服務供應商 (FSP) 市場：依階段

  • 概述
  • 臨床開發
  • 批准後

第八章全球功能服務供應商（FSP）市場：按應用

  • 概述
  • 生物製藥公司
  • 生物技術公司
  • 醫療器材公司
  • 研究中心、學術機構

第九章全球功能服務供應商（FSP）市場：按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 其他地區
    • 拉丁美洲
    • 中東
    • 非洲

第10章競爭格局

  • 概述
  • 競爭標桿
  • 全球功能服務供應商 (FSP) 市場的主要成長策略
  • 全球功能服務提供者（FSP）市場發展數量的主要參與者
  • 主要進展分析
  • 主要發展和增長戰略
    • 產品發布會
    • 合夥
    • 獲得
  • 主要公司財務矩陣
    • 銷售額 (2022)
    • 研發支出(2022年)

第十一章公司簡介

  • IQVIA INC.
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • ICON PLC
  • KPS LIFE, LLC
  • WUXI APPTEC CO., LTD.
  • PPD INC.
  • PAREXEL INTERNATIONAL CORPORATION
  • QUANTICATE INTERNATIONAL LIMITED
  • BIOPOINT INC.
  • RHO, INC.

第十二章附錄

Product Code: MRFR/HC/9296-CR

Market Overview

The Functional Service Providers (FSP) is anticipated to register a healthy CAGR of 7.49% during the review period.

This market is being driven by various elements, including expanding Research and development ventures, the rising number of clinical preliminaries, and the ascent of FSP outsourcing in drug improvement.

Rising Research and development speculations, particularly in the biopharmaceutical and biotechnology businesses, have made a requirement for functional service providers (FSPs) in the worldwide market. Research showed that the utilization of FSPs by enormous biopharmaceutical organizations is developing at a pace of over 13% yearly. These service providers offer staff to biopharmaceutical and biotechnology organizations for their exploration and advancement projects. They give profoundly qualified research partners, information supervisors, concentrate on organizers, clinical screens, and other related staff backing to these organizations.

Moreover, FSPs offer arrangements like preliminary administration, clinical checking, information the executives, factual programming, biostatistics, clinical composition, lifecycle security, and administrative undertakings. The tedious and costly nature of clinical preliminaries and the issues brought about by the high responsibility bring about the rising notoriety of FSPs. These providers save the organization time and lessen functional expenses.

Segment Insights

Segmentation of the global functional service provider market by type includes clinical monitoring, medical publishing, data management, pharmacovigilance, biostatistics/programming, regulatory, and others.

Based on phase, the global functional service provider market has been segmented into clinical trial phase and post-approval phase. Based on applications, the global functional service providers industry has been segmented into biopharmaceutical companies, biotechnology companies, medical device companies, and research centers and hubs. University institutes.

Regional Insights

The North America functional service providers market represented the biggest market with a portion of roughly 41% in 2022, because of the created medical care foundation, countless clinical preliminaries, and the presence of significant central participants in the region like IQVIA (US), Parexel (US), and Labcorp Medication Improvement (US).

Europe functional service supplier market represented the second-biggest market share because of innovation headways, expanding medical care consumption, and expanding predominance of ongoing sicknesses. As per the EMA, around 4,000 clinical preliminaries happen consistently across the European Association (EU) nations. Moreover, the Germany functional service supplier held the biggest market share in 2022, and the France functional service providers is extended be the quickest developing market in the Europe region.

The Asia-Pacific functional service providers market is supposed to be the quickest developing from 2023 to 2027 attributable to high understanding populace, decreased expenses of leading preliminaries, and great administrative arrangements. Also, central members working in the Functional Service Providers (FSP) Market are effectively venturing into Asia-Pacific region. For example, in July 2018, Parexel (US) laid out another auxiliary called Wellbeing Advances in Hong Kong to grow its capacities in the APAC region.

Major Players

Key Companies in the Functional Service Providers Market are Quanticate International Limited (UK), IQVIA, Inc. (US), BioPoint Inc. (US), Rho, Inc. (US), KPS Life, LLC (US), Parexel International Corporation (US), Laboratory Corporation of America Holdings (US), Wuxi Apptec co., Ltd. (China), Icon Plc (Ireland), and PPD Inc. (US).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE
  • 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING R&D INVESTMENTS
    • 4.2.2 RISING NUMBER OF CLINICAL TRIALS
    • 4.2.3 LOWERED OPERATIONAL COSTS AND IMPROVED SERVICE QUALITY
    • 4.2.4 RISE IN FSP OUTSOURCING IN DRUG DEVELOPMENT
  • 4.3 RESTRAINTS
    • 4.3.1 DEARTH OF SKILLED LABOR
  • 4.4 OPPORTUNITIES
    • 4.4.1 BIOPHARMA AND BIOTECH'S DIGITAL TRANSFORMATION

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)
    • 5.1.2 SERVICE CUSTOMIZATION
    • 5.1.3 CUSTOMER PURCHASE SUPPORT
    • 5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON FUNCTIONAL SERVICE PROVIDERS MARKET
    • 5.3.1 OVERVIEW
    • 5.3.2 IMPACT ON DEMAND FOR FUNCTIONAL SERVICE PROVIDERS (FSP)

6 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET BY TYPE

  • 6.1 OVERVIEW
  • 6.2 CLINICAL MONITORING
  • 6.3 MEDICAL WRITING
  • 6.4 DATA MANAGEMENT
  • 6.5 PHARMACOVIGILANCE
  • 6.6 BIOSTATISTICS/PROGRAMMING
  • 6.7 REGULATORY AFFAIRS
  • 6.8 OTHERS

7 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET BY STAGE

  • 7.1 OVERVIEW
  • 7.2 CLINICAL DEVELOPMENT
  • 7.3 POST APPROVAL

8 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET BY APPLICATION

  • 8.1 OVERVIEW
  • 8.2 BIOPHARMA COMPANIES
  • 8.3 BIOTECH COMPANIES
  • 8.4 MEDICAL DEVICES COMPANIES
  • 8.5 RESEARCH CENTER AND ACADEMIC INSTITUTES

9 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 UK
    • 9.3.3 FRANCE
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 AUSTRALIA
    • 9.4.5 SOUTH KOREA
    • 9.4.6 REST OF ASIA-PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 LATIN AMERICA
    • 9.5.2 MIDDLE EAST
    • 9.5.3 AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 COMPETITIVE BENCHMARKING
  • 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
  • 10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
  • 10.5 KEY DEVELOPMENT ANALYSIS
  • 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.6.1 PRODUCT LAUNCHES
    • 10.6.2 PARTNERSHIPS
    • 10.6.3 ACQUISITIONS
  • 10.7 MAJOR PLAYERS FINANCIAL MATRIX
    • 10.7.1 SALES (USD MILLION), 2022
    • 10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

11 COMPANY PROFILES

  • 11.1 IQVIA INC.
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 SOLUTIONS/SERVICES OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 LABORATORY CORPORATION OF AMERICA HOLDINGS
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS/SERVICES OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 ICON PLC
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS/SERVICES OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 KPS LIFE, LLC
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS/SERVICES OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 KEY STRATEGIES
  • 11.5 WUXI APPTEC CO., LTD.
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 SOLUTIONS/SERVICES OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 PPD INC.
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 SOLUTIONS/SERVICES OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 KEY STRATEGIES
  • 11.7 PAREXEL INTERNATIONAL CORPORATION
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS/SERVICES OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 KEY STRATEGIES
  • 11.8 QUANTICATE INTERNATIONAL LIMITED
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS/SERVICES OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 KEY STRATEGIES
  • 11.9 BIOPOINT INC.
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS/SERVICES OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 KEY STRATEGIES
  • 11.10 RHO, INC.
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS/SERVICES OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 4 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR CLINICAL MONITORING, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR MEDICAL WRITING, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR DATA MANAGEMENT, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 7 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR PHARMACOVIGILANCE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR BIOSTATISTICS/PROGRAMMING, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 9 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR REGULATORY AFFAIRS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR OTHERS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 12 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR CLINICAL DEVELOPMENT, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR POST APPROVAL, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 15 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR BIOPHARMA COMPANIES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR BIOTECH COMPANIES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR MEDICAL DEVICES COMPANIES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR RESEARCH CENTER AND ACADEMIC INSTITUTES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 20 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 21 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 22 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 23 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 24 US: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 25 US: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 26 US: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 27 CANADA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 28 CANADA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 29 CANADA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 30 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 31 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 32 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 33 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 34 GERMANY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 35 GERMANY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 36 GERMANY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 37 UK: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 38 UK: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 39 UK: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 40 FRANCE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 41 FRANCE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 42 FRANCE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 43 ITALY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 44 ITALY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 45 ITALY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 46 SPAIN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 47 SPAIN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 48 SPAIN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 49 REST OF EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 50 REST OF EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 51 REST OF EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 52 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 53 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 54 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 55 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 56 CHINA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 57 CHINA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 58 CHINA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 59 JAPAN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 60 JAPAN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 61 JAPAN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 62 INDIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 63 INDIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 64 INDIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 65 AUSTRALIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 66 AUSTRALIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 67 AUSTRALIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 68 SOUTH KOREA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 69 SOUTH KOREA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 70 SOUTH KOREA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 71 REST OF ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 72 REST OF ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 73 REST OF ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 74 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 75 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 76 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 77 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 78 LATIN AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 79 LATIN AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 80 LATIN AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 81 MIDDLE EAST: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 82 MIDDLE EAST: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 83 MIDDLE EAST: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 84 AFRICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 85 AFRICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2018-2027 (USD MILLION)
  • TABLE 86 AFRICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 87 MAJOR PLAYERS IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
  • TABLE 88 MOST ACTIVE PLAYERS IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
  • TABLE 89 PRODUCT LAUNCHES
  • TABLE 90 PARTNERSHIPS
  • TABLE 91 ACQUISITIONS
  • TABLE 92 IQVIA INC.: SOLUTIONS/SERVICES OFFERED
  • TABLE 93 IQVIA INC.: KEY DEVELOPMENTS
  • TABLE 94 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES OFFERED
  • TABLE 95 LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY DEVELOPMENTS
  • TABLE 96 ICON PLC: PRODUCTS/SERVICES OFFERED
  • TABLE 97 KPS LIFE, LLC: PRODUCTS/SERVICES OFFERED
  • TABLE 98 WUXI APPTEC CO., LTD.: SOLUTIONS/SERVICES OFFERED
  • TABLE 99 WUXI APPTEC CO., LTD.: KEY DEVELOPMENTS
  • TABLE 100 PPD INC.: SOLUTIONS/SERVICES OFFERED
  • TABLE 101 PAREXEL INTERNATIONAL CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 102 PAREXEL INTERNATIONAL CORPORATION: KEY DEVELOPMENTS
  • TABLE 103 QUANTICATE INTERNATIONAL LIMITED: PRODUCTS/SERVICES OFFERED
  • TABLE 104 QUANTICATE INTERNATIONAL LIMITED: KEY DEVELOPMENTS
  • TABLE 105 BIOPOINT INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 106 RHO, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 107 RHO, INC.: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
  • FIGURE 5 DRIVERS: IMPACT ANALYSIS
  • FIGURE 6 RESTRAINTS: IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS: FUNCTIONAL SERVICE PROVIDERS MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: FUNCTIONAL SERVICE PROVIDERS MARKET
  • FIGURE 9 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2022 & 2027 (USD MILLION)
  • FIGURE 10 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2022 & 2027 (USD MILLION)
  • FIGURE 11 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2022 & 2027 (USD MILLION)
  • FIGURE 12 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY REGION 2022 & 2027 (USD MILLION)
  • FIGURE 13 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET SHARE (%), BY REGION, 2022
  • FIGURE 14 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET SHARE (%), BY COUNTRY 2022
  • FIGURE 15 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 16 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 17 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET SHARE (%), BY REGION, 2022
  • FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 19 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET
  • FIGURE 20 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 21 SALES (USD MILLION), 2022
  • FIGURE 22 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022
  • FIGURE 23 IQVIA INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 24 IQVIA INC.: SWOT ANALYSIS
  • FIGURE 25 LABORATORY CORPORATION OF AMERICA HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 26 LABORATORY CORPORATION OF AMERICA HOLDINGS: SWOT ANALYSIS
  • FIGURE 27 ICON PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 28 ICON PLC: SWOT ANALYSIS
  • FIGURE 29 WUXI APPTEC CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 30 WUXI APPTEC CO., LTD.: SWOT ANALYSIS
  • FIGURE 31 PPD INC.: FINANCIAL OVERVIEW SNAPSHOT